"We Envision Growth Strategies Most Suited
to Your Business"
Traditionally followed as symbolic parsing and rule based systems, clinical Natural Language Processing (NLP) has undergone a huge transformation through different statistical methods of modern neural networks and transformed powered frameworks. Early research had laid a basis for tokenization and pattern identification, while current surveys tend to represent the advances and challenges in the adoption, interpretability and secure handling of sensitive health insights.
Leading technology companies and prominent healthcare vendors are seeking innovation in electronic health records through automated clinical coding, with research laboratories developing task specific transformer models. These emerging developments focus on privacy, federated learning collaborations and modern entity recognition that ensures to reduce the administrative burden.
Fortune Business Insights reported that the market for clinical NLP platforms is observing a substantial growth with a CAGR of 23.33% and is expected to reach a revenue of USD 2.46 billion in 2026 and increase to USD 13.15 billion by 2034.
Amazon Web Services, Inc., is one of the top 10 clinical NLP platform companies, headquartered in the U.S. The company provides Amazon Comprehend Medical, a HIPAA-eligible NPL service that is particularly designed for the life sciences and healthcare industry. It uses machine learning to extract structured medical information from unstructured clinical data including prescriptions, doctor notes, and Electronic Health Records (EHRs). The company, at re:Invent 2025, introduced the Amazon Nova 2 Lite and Nova 2 Omni models that are capable of analyzing medical images, structured clinical records, text, and video in a single, unified workflow.
Microsoft’s clinical NPL platforms are based into the Azure AI portfolio, particularly designed to unlock the insights from unstructured medical insights including reports, and EHR. The company primarily offers Text Analytics for health, a specialized feature within the Azure AI services that extracts and labels medical data including medications, symptoms and dosages, mapping them to a standard clinical coding system. In March 2025, the company introduced Microsoft Dragon Copilot, the first AI assistant for clinical workflow that unifies trusted natural language voice dictation capabilities of DMO with the ambient listening capabilities of DAX.
Google Cloud is known for its exclusive suite of clinical NLP platforms that are particularly designed for structuring, analyzing and deriving the insights from unstructured medical data including reports, notes and doctor-patient conversations. These solutions are based on Google’s advanced AI research and are designed for enhancing efficiency, patient care, and reducing administrative burdens for increased accuracy in identifying the medical issues in a patient.
IQVIA’s clinical NLP platform is powered by Linguamatics, (acquired by IQVIA). This is an award-winning and leading NLP solution designed for extracting insights from unstructured texts across the life science and healthcare landscape. This platform is being used by most of the pharmaceutical companies and governments to convert the texts from clinical notes, scientific literature and medical records into actionable insights by reducing the time and cost. In January 2025, the firm collaborated with NVIDIA to build the custom foundation models and agentic AI workflow for clinical trials and regulatory compliance.
John Snow Labs, Inc., offers a state-of-the-art AI, providing over 2,400 pre-trained models and tools, as well as software to gain data from unstructured clinical texts. These data are used for tasks such as summarization, recognition and de-identification, thus powering the research agencies and pharmaceuticals with scalable NPL solutions for accurate analysis. This platform also allows for building a custom AI solution with expert support and easy integration into current infrastructure.
A German based company, Averbis GmbH, was founded in 2007 and is a leading provider of AI based text analytics and NLP solutions. This platform, widely known as Averbis Health Discovery, is focused on providing outputs for the life science and healthcare sector. It is designed to transform the unstructured data from nursing narratives, pathology reports and doctor’s reports into actionable information. It is widely used for clinical decision support, research, automated billing & coding, and rare disease detection.
A specialized Clinical NLP platform, Clinithink, offers an exclusive AI based solution named CLiX. This platform was founded in 2009 and focuses on transforming the clinical narratives into structured and actionable data, to enhance the clinical trial recruitment and improve the real-world evidence generation. The company operates in Europe and North America by significantly collaborating with companies including AstraZeneca and various other NHS trusts.
nference, Inc., is known for offering clinical NLP solutions through one of its flagship products, nSights. It transforms a huge volume of unstructured medical data into actionable, and computable, research ready data. It focuses on augmented curation with the use of neural networks and large language models to extract data from over 1.4 billion clinical notes. This platform also employs AI to interpret large data and hidden patterns during the patient journey.
Formerly known as 3M Health Information Systems, Solventum, offers a unified AI based clinical NLP platform that is designed to automate clinical documents and enhance coding accuracy. This platform is powered by the legacy and innovation of 3M M*Modal technology that is adopted by more than 250 companies. In January 2026, the company launched Solventum Fluency Align, an ambient AI documentation solution that is aligned with MEDITECH.
CodaMetrix’s Clinical NLP solutions is AI based that automates different multi-specialty medical coding with the use of machine learning and deep learning. This aids in high accuracy while billing and diagnostic codes, reducing manual work and improving efficiency. The company, in 2023, raised around USD 55 million digital health funding to speed the go-to-market efforts with other health systems and organizations.
In the future, the industry is likely to become an indispensable part of the digital healthcare system. With models evolving from traditional text analysis to real-time clinical cognition, these platforms are expected to operate as a core by continuously learning from the clinical interactions. Advancements in combining text with imaging, multimodal AI, genomics and sensor data could also reshape the clinical knowledge and its generation. This highlights that technological upgradation would shift the process of clinical knowledge optimization and consumption.
+1 833 909 2966 ( Toll Free ) (US)
sales@fortunebusinessinsights.com